Cancer
Control
RTOG
R0614 Consent
HIPAA
Protocol
(closed 07/21/10)
A Randomized, Phase III, Double-blind,
Placebo-Controlled Trial of Memantine for
Prevention of Cognitive Dysfunction in Patients
Receiving Whole-brain Radiotherapy
RTOG R0517
Consent
HIPAA
Protocol
Pre-registration requirements (see protocol
section 5.0)
Randomized Phase III trial to Evaluate
Radiopharmaceuticals and Zoledronic Acid in the
Palliation of Osteoblastic Metastases from Lung,
Breast and Prostate Cancer
RTOG R0831
Consent
QOL
Consent
HIPAA
Protocol
(temporary closure)
A Randomized,
Double-Blinded, Placebo-Controlled Phase III
Trial to Evaluate the Effectiveness of a
Phosphodiesterase 5 Inhibitor, Tadalafil, in
Prevention of Erectile Dysfunction in Patients
Treated With Radiotherapy for Prostate Cancer
BRAIN
RTOG R0825 Consent
HIPAA
Protocol
Phase III Double-Blind Placebo-Controlled Trial
of Conventional Concurrent Chemoradiation and
Adjuvant Temozolomide plus Bevacizumab versus
Conventional Concurrent Chemoradiation and
Adjuvant Temozolomide in Patients with
Newly-Diagnosed Glioblastoma
CTSU E3F05 Consent
HIPAA
Protocol
Phase III Study of Radiation Therapy with or
without Temozolomide for Symptomatic or
Progressive Low-Grade Gliomas
RTOG R0539 Consent
HIPAA
Protocol
Phase II Trial of Observation for Low-Risk Meningiomas and of Radiotherapy for
Intermediate- and High-Risk
NCCTG N057K Consent
HIPAA
Protocol
Phase I/II Evaluation of Everolimus (RAD001),
Radiation and Temozolomide (TMZ) Followed by
Adjuvant Temozolomide and Everolimus in Newly
Diagnosed Glioblastoma
Brain Mets
NCCTG N0574
Consent
HIPAA
Protocol
Phase III Randomized Trial of the
Role of Whole Brain Radiation Therapy in Addition to Radiosurgery in Patients
with One to Three Cerebral Metastases
BREAST
NSABP B-39
Consent
HIPAA
Fast Facts
Protocol
(Closed to specific patients)
A Randomized Phase III Study of Conventional
Whole Breast Irradiation versus Partial Breast Irradiation for Women with Stage
0, I or II Breast Cancer
Breast - Metastatic
RTOG R0517
Consent
HIPAA
Protocol
Pre-registration requirements (see section 5.0
of the protocol)
Randomized Phase III trial to Evaluate
Radiopharmaceuticals and Zoledronic Acid in the
Palliation of Osteoblastic Metastases from Lung,
Breast and Prostate Cancer
GASTROINTESTINAL
Colon - Rectal
Rectal
NSABP R-04
Consent
HIPAA
Fast Facts
Protocol
A Clinical Trial Comparing Preoperative Radiation Therapy and
Capecitabine with Preoperative Radiation Therapy and Continuous Intravenous Infusion of
5-Fluorouracil in the Treatment of Patients with Operable Carcinoma of the Rectum
Stomach
Esophageal
RTOG R0436
Consent
HIPAA
Protocol
Treatment Calendar Arm 1
Arm 2
A Phase III Trial Evaluating the Addition of Cetuximab to Paclitaxel, Cisplatin, and
Radiation for Patients With Esophageal Cancer
Who Are Treated Without Surgery
Pancreas
RTOG R0848 Consent
HIPAA Protocol Treatment
Calendar Arm 1
Arm 2
Arm 3(1)
Arm 3(2)
Arm 4(1)
Arm 4(2)
A Phase III Trial
Evaluating Both Erlotinib and Chemoradiation as
Adjuvant
Treatment for Patients with Resected Head of
Pancreas Adenocarcinoma
Gallbladder
GENITOURINARY
Prostate
CTSU MDA-3410
Consent
HIPAA
Fast Facts
Protocol
A Prospective Randomized Phase II Trial Comparing
Consolidation Therapy With or Without Strontium-89 Following Induction
Chemotherapy in Androgen-Independent Prostate Cancer
RTOG R0517
Consent
HIPAA
Protocol
Pre-registration requirements (see section 5.0
of the protocol)
Randomized Phase III trial to Evaluate
Radiopharmaceuticals and Zoledronic Acid in the
Palliation of Osteoblastic Metastases from Lung,
Breast and Prostate Cancer
RTOG R0534
Consent
HIPAA
Protocol
A Phase III Trial
Of Short Term Androgen Deprivation With Pelvic
Lymph Node Or Prostate Bed Only Radiotherapy
(SPORT) In Prostate Cancer Patients With A
Rising PSA After Radical Prostatectomy
RTOG R0622
Consent
HIPAA
Protocol
A Phase II Trial of Samarium 153 Followed by
Salvage Prostatic Fossa 3D-CRT or IMRT
Irradiation in High-Risk, Clinically
Non-Metastatic Prostate Cancer After Radical
Prostatectomy
RTOG R0815 Consent
HIPAA
Protocol
A Phase III
Prospective Randomized Trial of Dose-Escalated
Radiotherapy With or Without Short-Term Androgen
Deprivation Therapy for Patients With
Intermediate-Risk Prostate Cancer
Bladder/Urothelium
RTOG R0524
Consent
HIPAA
Protocol
A Phase I/II Trial
of a Combination of Paclitaxel and Trastuzumab with Daily Irradiation or
Paclitaxel Alone with Daily Irradiation Following Tranurethral Surgery for Non-Cystectomy
Candidates with Muscle-Invasive Bladder Cancer
Germ Cell Malignancies
Renal
GYNECOLOGIC
Ovarian
Cervical
Endometrial
HEAD & NECK
RTOG R0920
Consent
HIPAA
Protocol
A Phase III Study of
Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced
Resected Head and Neck Cancer
LEUKEMIA
Acute Leukemia
Chronic Leukemia
LUNG
Non-Small Cell
CTSU
C30610 Consent
HIPAA
Protocol
Phase III Comparison of Thoracic Radiotherapy
Regimens in Patients with Limited Small Cell
Lung Cancer also Receiving Cisplatin and
Etoposide
RTOG R0517
Consent
HIPAA
Protocol
Pre-registration requirements (see section 5.0
of the protocol)
Randomized Phase III trial to Evaluate
Radiopharmaceuticals and Zoledronic Acid in the
Palliation of Osteoblastic Metastases from Lung,
Breast and Prostate Cancer
RTOG R0617
Consent
HIPAA
Protocol
A
Randomized Phase III Comparison of
Standard-Dose (60 Gy) Versus High-Dose (74
Gy) Conformal Radiotherapy with Concurrent
and Consolidation Carboplatin/Paclitaxel in
Patients With Stage IIIA/IIIB Non-Small Cell
Lung Cancer
RTOG R0915 Consent
HIPAA
Protocol
A Randomized Phase II Study Comparing 2
Stereotactic Body Radiation Therapy (SBRT)
Schedules for Medically Inoperable Patients with
Stage I Peripheral Non-Small Cell Lung Cancer
Small
Cell
RTOG R0937
Consent
HIPAA
Protocol
Randomized Phase II Study Comparing Prophylactic
Cranial Irradiation Alone to Prophylactic
Cranial Irradiation and Consolidative
Extra-Cranial Irradiation for Extensive Disease
Small Cell Lung Cancer (ED_SCLC)
LYMPHOMA
Hodgkin's
Non-Hodgkin's
Mantle
Cell
Melanoma
Myeloma
Sarcoma
Other
RTOG R0631 Consent
HIPAA
Protocol
Phase II/III Study of Image-Guided Radiosurgery/SBRT
for Localized Spine Metastasis
Return to the Top